These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 10206320)

  • 1. Azimilide pharmacokinetics and pharmacodynamics upon multiple oral dosing.
    Corey A; Al-Khalidi H; Brezovic C; Marcello S; Parekh N; Taylor K; Karam R
    Biopharm Drug Dispos; 1999 Mar; 20(2):59-68. PubMed ID: 10206320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics following intravenous doses of azimilide dihydrochloride.
    Corey A; Agnew J; Brum J; Parekh N; Valentine S; Williams M
    J Clin Pharmacol; 1999 Dec; 39(12):1263-71. PubMed ID: 10586392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of severe renal impairment on the pharmacokinetics of azimilide following single dose oral administration.
    Corey AE; Agnew JR; Valentine SN; Parekh NJ; Powell JH; Thompson GA
    Br J Clin Pharmacol; 2002 Nov; 54(5):449-52. PubMed ID: 12445022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population pharmacokinetic-pharmacodynamic analysis and model validation of azimilide.
    Phillips L; Grasela TH; Agnew JR; Ludwig EA; Thompson GA
    Clin Pharmacol Ther; 2001 Oct; 70(4):370-83. PubMed ID: 11673753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azimilide pharmacokinetics following intravenous and oral administration of a solution and capsule formulation.
    Corey AE; Agnew JR; Valentine SN; Nesbitt JD; Wagner DL; Powell JH; Thompson GA
    J Clin Pharmacol; 1999 Dec; 39(12):1272-6. PubMed ID: 10586393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of age and gender on azimilide pharmacokinetics after a single oral dose of azimilide dihydrochloride.
    Corey A; Agnew J; Bao J; Bryson P; Comer P; Griffith S; Li J
    J Clin Pharmacol; 1997 Oct; 37(10):946-53. PubMed ID: 9505986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of azimilide on CYP2C19-mediated metabolism.
    El Mouelhi M; Worley DJ; Kuzmak B; Destefano AJ; Thompson GA
    J Clin Pharmacol; 2004 Apr; 44(4):373-8. PubMed ID: 15051744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of coadministration on the pharmacokinetics of azimilide dihydrochloride and digoxin.
    Toothaker RD; Corey AE; Valentine SN; Agnew JR; Parekh N; Moehrke W; Thompson GA; Powell JH
    J Clin Pharmacol; 2005 Jul; 45(7):773-80. PubMed ID: 15951467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of azimilide on heart rate and ECG conduction intervals during sinus rhythm in patients with a history of atrial fibrillation.
    Pritchett EL; Schulte MC; Schnell D; Marcello SR; Wilkinson WE; Page RL; Connolly SJ;
    J Clin Pharmacol; 2002 Apr; 42(4):388-94. PubMed ID: 11936563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azimilide.
    Clemett D; Markham A
    Drugs; 2000 Feb; 59(2):271-7; discussion 278-9. PubMed ID: 10730550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of intravenous azimilide on cardiac performance, fibrillation threshold, and hemodynamics in anesthetized dogs.
    Brooks RR; Finch SL
    Arzneimittelforschung; 2000 Jul; 50(7):597-605. PubMed ID: 10965415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azimilide. NE 10064, Stedicor.
    Drugs R D; 1999 Apr; 1(4):297-300. PubMed ID: 10566048
    [No Abstract]   [Full Text] [Related]  

  • 13. Symptoms at the time of arrhythmia recurrence in patients receiving azimilide for control of atrial fibrillation or flutter: results from randomized trials.
    Connolly SJ; Schnell DJ; Page RL; Wilkinson WE; Marcello SR; Pritchett EL;
    Am Heart J; 2003 Sep; 146(3):489-93. PubMed ID: 12947368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of ketoconazole on azimilide pharmacokinetics in healthy subjects.
    El Mouelhi M; Worley DJ; Kuzmak B; Destefano AJ; Thompson GA
    Br J Clin Pharmacol; 2004 Dec; 58(6):641-7. PubMed ID: 15563362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The azimilide post-infarct survival evaluation (ALIVE) trial.
    Camm AJ; Karam R; Pratt CM
    Am J Cardiol; 1998 Mar; 81(6A):35D-39D. PubMed ID: 9537221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose-response relations of azimilide in the management of symptomatic, recurrent, atrial fibrillation.
    Connolly SJ; Schnell DJ; Page RL; Wilkinson WE; Marcello SR; Pritchett EL
    Am J Cardiol; 2001 Nov; 88(9):974-9. PubMed ID: 11703992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Azimilide dihydrochloride: a new class III anti-arrhythmic agent.
    Abrol R; Page RL
    Expert Opin Investig Drugs; 2000 Nov; 9(11):2705-15. PubMed ID: 11060832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of isoproterenol on the class III effect of azimilide in humans.
    Dorian P; Dunnmon P; Elstun L; Newman D
    J Cardiovasc Pharmacol Ther; 2002 Oct; 7(4):211-7. PubMed ID: 12490966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of azimilide dihydrochloride on circus movement atrial flutter in the canine sterile pericarditis model.
    Restivo M; Hegazy M; Caref EB; Avitable MJ; Assadi MA; el-Hamami M; Yin H; Piracha M; Brooks RR; el-Sherif N
    J Cardiovasc Electrophysiol; 1996 Jul; 7(7):612-24. PubMed ID: 8807407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of azimilide, a KV(r) and KV(s) blocker, on canine ventricular arrhythmia models.
    Xue Y; Yamada C; Chino D; Hashimoto K
    Eur J Pharmacol; 1999 Jul; 376(1-2):27-35. PubMed ID: 10440086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.